StemCell Therapy

Trending News: Hypothyroidism Linked to Increased All-Cause Mortality in Patients 60 Years or Older

Two migraine prevention agents, cinnarizine and sodium valproate, were shown to be safe and effective in reducing incidence and severity of migraine within children and adolescents, according to the American Journal of Managed Care. In a randomized double-blind placebo-controlled trial including 149 Iranian pediatric and adolescent patients, patients were randomly assigned at 1:1:1 ratio to receive cinnarizine, sodium valproate, or placebo. Compared with placebo, the 2 preventive agents exhibited significant reductions in migraine incidence and severity, warranting further analyses into their efficacy among the global population.

New research indicates that hypothyroidism could be linked to increased all-cause mortality in patients aged 60 years and older, according to MD Magazine. An international team of researchers conducted a systematic review and meta-analysis of PubMed, Embase, Cochrane Library, Scopus, and Web of Science databases. Their findings indicate that patients aged 60 years or older with subclinical hypothyroidism (those who have a milder thyroid dysfunction) may not benefit from a treatment with synthetic thyroid hormone.

Read more from the original source:
Trending News: Hypothyroidism Linked to Increased All-Cause Mortality in Patients 60 Years or Older - Pharmacy Times

This entry was posted on December 12, 2019 at 4:54 pm and is filed under Immune System. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |